AXT Inc is a semiconductor equipment & materials business based in the US. AXT shares (AXTI) are listed on the NASDAQ and all prices are listed in US Dollars. AXT employs 1,399 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $5.73 |
|---|---|
| 52-week range | $4.97 - $10.73 |
| 50-day moving average | $5.72 |
| 200-day moving average | $7.34 |
| Wall St. target price | $12.17 |
| PE ratio | 17.9063 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.32 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.73 from 2022-07-01
| 1 week (2022-06-28) | -3.05% |
|---|---|
| 1 month (2022-06-03) | -2.22% |
| 3 months (2022-04-05) | -15.49% |
| 6 months (2022-01-04) | -37.38% |
| 1 year (2021-07-02) | -46.40% |
|---|---|
| 2 years (2020-07-02) | 25.66% |
| 3 years (2019-07-05) | 39.08% |
| 5 years (2017-07-03) | 6.1 |
Valuing AXT stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AXT's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AXT's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, AXT shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
AXT's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.77. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AXT's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
AXT's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.5 million.
The EBITDA is a measure of a AXT's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $145.7 million |
|---|---|
| Operating margin TTM | 8.95% |
| Gross profit TTM | $47.4 million |
| Return on assets TTM | 2.55% |
| Return on equity TTM | 6.12% |
| Profit margin | 9.83% |
| Book value | $5.04 |
| Market capitalisation | $246.1 million |
TTM: trailing 12 months
We're not expecting AXT to pay a dividend over the next 12 months.
Over the last 12 months, AXT's shares have ranged in value from as little as $4.97 up to $10.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AXT's is 2.0939. This would suggest that AXT's shares are significantly more volatile than the average for this exchange and represent a higher risk.
AXT, Inc. designs, develops, manufactures, and distributes compound and single element semiconductor substrates. It produces semiconductor substrates using its proprietary vertical gradient freeze technology. The company offers indium phosphide for use in data center connectivity using light/lasers, 5G communications, fiber optic lasers and detectors, passive optical networks, silicon photonics, photonic integrated circuits, terrestrial solar cells, RF amplifier and switching, infrared light-emitting diode (LEDS) motion control, lidar for robotics and autonomous vehicles, and infrared thermal imaging. It also provides semi-insulating gallium arsenide (GaAs) substrates for use in Wi-Fi and IoT devices, transistors, direct broadcast television, power amplifiers, satellite communications, and solar cells; and semi-conducting GaAs substrates that are used in LED, screen displays, printer head lasers and LEDs, 3-D sensing using VCSELs, data center communication using VCSELs, sensors for industrial robotics/near-infrared sensors, optical couplers, solar cells, night vision goggles, lidar for robotics and autonomous vehicles, and other lasers, as well as laser machining, cutting, and drilling. In addition, the company offers germanium substrates for use in multi-junction solar cells for satellites, optical sensors and detectors, terrestrial concentrated photo voltaic cells, infrared detectors, and carrier wafer for LED. Further, it provides 6N+ and 7N+ purified gallium, boron trioxide, gallium-magnesium alloy, pyrolytic boron nitride (pBN) crucibles, and pBN insulating parts.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.